These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26673168)

  • 21. Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.
    Polisetty RV; Gautam P; Gupta MK; Sharma R; Gowda H; Renu D; Shivakumar BM; Lakshmikantha A; Mariswamappa K; Ankathi P; Purohit AK; Uppin MS; Sundaram C; Sirdeshmukh R
    Sci Rep; 2016 Jun; 6():26882. PubMed ID: 27246909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison.
    Sharma I; Siraj F; Sharma KC; Singh A
    J Cancer Res Ther; 2016; 12(2):793-7. PubMed ID: 27461653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
    El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
    Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
    Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
    Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.
    Fontebasso AM; Shirinian M; Khuong-Quang DA; Bechet D; Gayden T; Kool M; De Jay N; Jacob K; Gerges N; Hutter B; Şeker-Cin H; Witt H; Montpetit A; Brunet S; Lepage P; Bourret G; Klekner A; Bognár L; Hauser P; Garami M; Farmer JP; Montes JL; Atkinson J; Lambert S; Kwan T; Korshunov A; Tabori U; Collins VP; Albrecht S; Faury D; Pfister SM; Paulus W; Hasselblatt M; Jones DT; Jabado N
    Oncotarget; 2015 Oct; 6(31):31844-56. PubMed ID: 26378811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers.
    Dreyfuss JM; Johnson MD; Park PJ
    Mol Cancer; 2009 Sep; 8():71. PubMed ID: 19732454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
    Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
    Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
    Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
    Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
    Rempel SA; Dudas S; Ge S; Gutiérrez JA
    Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.
    Lambert SR; Witt H; Hovestadt V; Zucknick M; Kool M; Pearson DM; Korshunov A; Ryzhova M; Ichimura K; Jabado N; Fontebasso AM; Lichter P; Pfister SM; Collins VP; Jones DT
    Acta Neuropathol; 2013 Aug; 126(2):291-301. PubMed ID: 23660940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
    Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
    Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrent astrocytoma versus primary astrocytoma: a comparative study of morphological changes of 32 cases].
    Hu Y; Hang Z; Ouyang M
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):91-3. PubMed ID: 8070783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset.
    Jentoft M; Giannini C; Cen L; Scheithauer BW; Hoesley B; Sarkaria JN; Abell-Aleff PC; Rodriguez EF; Li Y; Rodriguez FJ
    Int J Clin Exp Pathol; 2010 Dec; 4(1):43-57. PubMed ID: 21228927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
    Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
    Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.